Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Human papilloma virus (HPV) vaccination in perspective

Written by | 12 Mar 2021

Interview and article by Christine Clark In the first ten years of the UK national HPV vaccination programme more than ten million doses of HPV vaccine were given… read more.

EMA plans rapid approval of vaccines against COVID-19 variants

Written by | 12 Mar 2021

Article written by Gary Finnegan. New COVID-19 vaccines against variants of the virus could be approved much more quickly than the first generation of jabs. The European Medicines… read more.

AstraZeneca Pharma India announces marketing approval for Tagrisso (Osimertinib)

Written by | 11 Mar 2021

AstraZeneca Pharma India Limited announced that it has received marketing approval for Tagrisso (Osimertinib) for adjuvant treatment after complete tumour resection in patients with non-small cell lung cancer… read more.

Biktarvy shows high efficacy and durable viral suppression in treatment-naïve adults with HIV-1 in four-year data presented at CROI – Gilead Sciences

Written by | 11 Mar 2021

Gilead Sciences, Inc. announced new, long-term data from open-label extensions (OLE) of two Phase III studies (Study 1489 and Study 1490) of Biktarvy (bictegravir 50 mg/emtricitabine 200 mg/tenofovir… read more.

Fauci vs Kardashian: the public prefers health tips from experts

Written by | 11 Mar 2021

Article written by Gary Finnegan. People are more willing to reshare calls for social distancing if the message is endorsed by a well-known expert – such as US… read more.

Human papilloma virus (HPV) vaccines and vaccination strategy

Written by | 11 Mar 2021

Interview and article by Christine Clark Dr Peter English, a consultant in communicable disease control describes the UK HPV vaccination strategy and the associated issues. Dr Peter English,… read more.

COVID lockdown hits air ambulance services in remote Australia

Written by | 10 Mar 2021

Article written by Gary Finnegan. New data released by Australian researchers reveals the impact of the COVID-19 lockdown period on aeromedical retrievals in rural and remote regions. Researchers… read more.

Human papilloma virus (HPV) and cervical cancer

Written by | 10 Mar 2021

Interview and article by Christine Clark Cervical cancer accounts for about 850 cancer deaths in the UK every year – more than two every day – and yet… read more.

Roche announces results from Evrysdi study in infants with Type 1 spinal muscular atrophy (SMA) published in NEJM

Written by | 9 Mar 2021

Roche announced that the New England Journal of Medicine has published Evrysdi (risdiplam) data from the dose finding Part 1 of the pivotal FIREFISH study in infants with… read more.

Face masks reduced spread of COVID-19 during first wave

Written by | 9 Mar 2021

Article written by Gary Finnegan. Face masks likely played a role in reducing the spread of SARS-CoV-2 in Italy during the first half of 2020, according to a… read more.

Phase III study of Covaxin reports efficacy of 80.6% in COVID-19 – Ocugen/Bharat Biotech

Written by | 8 Mar 2021

Ocugen announced that its co-development partner, Bharat Biotech, announced the results of the first interim analysis of its Phase III study of Covaxin, a whole virion inactivated COVID-19… read more.

Prolonged high-dose hormone linked to tumour risk

Written by | 8 Mar 2021

Article written by Gary Finnegan. A study of more than 250,000 women in France has found that prolonged high dose use of cyproterone acetate is associated with an… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.